Skip to content
Top Menu
July 5, 2025
  • About Us
  • Contact Details
  • Grievance
  • Privacy Policy
  • Terms Of Use
  • Facebook
  • Twitter
  • Instagram
  • Youtube
The Samikhsya

The Samikhsya

Odia
  • Home
  • Special
  • National
  • Business
  • Entertainment
  • Culture
  • International
  • Sports
  • Sc & Tech
  • Health
Main Menu

Tag: Bharat Biotech Ltd

National / News Update

DCGI approves Phase 2,3 clinical trial of Covaxin in the age group of 2 to 18 Years

May 13, 2021 - by The Samikhsya

New Delhi, The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission …

DCGI approves Phase 2,3 clinical trial of Covaxin in the age group of 2 to 18 Years Read More

Business News

  • Aviva Life Insurance Wins Product of the Year 2025

    Aviva Life Insurance Wins Product of the Year 2025

  • India Toy Export Growth: 153 Nations Now Importing, Says Piyush Goyal

    India Toy Export Growth: 153 Nations Now Importing, Says Piyush Goyal

  • Sony India Launches Next-Gen 4K Experience, Know Price and Features

    Sony India Launches Next-Gen 4K Experience, Know Price and Features

  • SAIL in Dubai: Opens Representative Office to Strengthen Global Presence

    SAIL in Dubai: Opens Representative Office to Strengthen Global Presence

  • Reliance Retail Enters Global Beauty Arena with UK Based FaceGym Investment

    Reliance Retail Enters Global Beauty Arena with UK Based FaceGym Investment

  • Bharat Gaurav Tourist Train: Explore the Spiritual Heart of Dakshin Bharat 

    Bharat Gaurav Tourist Train: Explore the Spiritual Heart of Dakshin Bharat 

  • Fashion Factory Branded Exchange Fest: Swap & Save Big

    Fashion Factory Branded Exchange Fest: Swap & Save Big

  • NTPC Bongaigaon Launches Girl Empowerment Mission 2025 

    NTPC Bongaigaon Launches Girl Empowerment Mission 2025 

Copyright © 2025 The Samikhsya. Chief Editor- Sarat Paikray
Powered by WordPress and HitMag.